OBJECTIVE: Our purpose was to identify clinically relevant differences in w
omen with primary and recurrent pelvic organ prolapse.
STUDY DESIGN: Consecutive women undergoing reconstructive surgery completed
a urogynecologic history and physical examination and underwent either mul
tichannel urodynamic testing or pelvic floor fluoroscopy, or both. Two grou
ps were compared: primary (no prior surgery for pelvic organ prolapse) and
recurrent.
RESULTS: One hundred eighty-one consecutive women were studied-103 with pri
mary and 78 with recurrent prolapse. The groups were similar with respect t
o age, race, weight, vaginal parity, prolapse stage, urodynamic diagnosis,
extent of visceral malposition, and common urinary, anorectal, and sexual s
ymptoms. Clinically relevant differences were found, with the recurrent gro
up having shorter vaginal lengths (P=.0005), being more likely to have had
a hysterectomy for a nonprolapse indication (P=.00018) and to be receiving
hormone replacement therapy (P=.00003).
CONCLUSION: The women with primary and recurrent pelvic organ prolapse in t
his population were remarkably similar in many quantifiable parameters meas
ured. The clinical differences may be related to previous surgery for pelvi
c organ prolapse.